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The paper by van Dongen et al. [1] in this issue is to be
commended on many levels. It contributes substantially to
the blood donor recruitment and mere-measurement literatures
and highlights the importance of replication. Importantly, it
opens up the debate on the causes and consequences of non-
compliance in randomised controlled trials (RCTs) in behav-
ioural medicine. Non-compliance introduces non-random se-
lection bias to RCTs and has implications for causality,
generalizability and policy [2–5]. Therefore, reducing bias
caused by non-compliance either methodologically or statisti-
cally is important.
Methodological solutions to this bias are less likely to be
used than statistical ones, due, in part, to the lack of coherent
frameworks to understand non-compliance. Indeed, as vanDon-
gen et al. [1] highlight, non-compliance is complex, arising from
person characteristics (e.g. attitudes to trials and conscientious-
ness), intervention idiosyncrasies or person/intervention interac-
tions [6]. A first step in a methodological solution would be to
identify psychological (traits, attitudes, beliefs) and demograph-
ic characteristics that differentiate compliant from non-
compliant behaviour in treatment and control arms of trials. A
framework developed by Angrist and colleagues offers a useful
starting point [2–4]. This model identifies four groups [2–4].
The first group comply with the intervention protocol regardless
of their assignment to the treatment or control arms: these are
called compliers. The second group comply only if allocated to
the treatment but not the control arm: called always-takers or
may also be termed treatment only compliers. The third group
comply if allocated to the control but not the treatment arm: the
never-takers or control only compliers. The final group—defiers
—do not comply with whichever arm they are allocated. Using
these groups, non-compliance could be studied at a general or
trial-specific level. At a general level, these four groups could be
identified with respect to stable preferences to comply or not
with treatment or control arm protocols across a variety of
RCTs. Any stable psychological and demographic differences
across these groups could be fed into compliance enhancing
designs. For a specific RCT, it would be possible to explore how
different intervention protocols influence who are likely to be
treatment-only and control-only compliers and this information
used to enhance compliance in both treatment and control arms.
For example, in general, financially incentivized questionnaires
(treatment arm) increase compliance relative to non-incentivized
questionnaires (control arm) [7]. However, for blood donors,
financially incentivized questionnaires may be either counter-
productive [8] or helpful [9–13] for compliance. Identifying if
incentivizing questionnaires increase the number of control only
compliers (those preferring the non-incentivized questionnaire)
and why will help to inform the intervention design and its
interpretation.
If bias due to non-compliance cannot be designed out, it
needs to be addressed statistically [2–5]. van Dongen et al. [1]
call for the use of instrumental variables (IVs) analysis. IVs
are designed to deal with problems of endogeneity (the ex-
planatory predictor is correlated with the error term, leading to
threats to causality due to missing variables, reverse causality
etc.) by isolating the variability in the predictor that is causally
related to the outcome [2–5, 14–18]. IVs have to be highly
correlated with the predictor (instrumental relevance) [14, 18],
influence the outcome only via the predictor, be orthogonal to
the error in the predictive model (instrumental exogeneity)
and require large Ns [3–5, 14–18]. Randomization can be used
as an instrument to adjust for threats arising from non-
compliance [2–5]. While policy questions of effectiveness
(What are the benefits from treatment assignment?) and treat-
ment questions of efficacy (What are the benefits of treatment
to patients?) can be analysed using intention to treat (ITT) and
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‘per protocol’ or ‘as treated’ analysis [5], the IVestimator for a
RCT adjusts the ITT by the proportion actually receiving the
treatment. This may account for why some studies with high
compliance (e.g. 82 %) [19] have observed a mere-
measurement effect with ITT analysis and others have not.
Finally, the use of IV analysis should be extended beyond
RCTs as it has in the education, economic and medicine
literature to infer causality when randomization is not possi-
ble, for example from survey data [15, 17, 18, 20]. Surpris-
ingly, IVanalyses have not been used in behavioural medicine
where such data are often collected. Therefore, van Dongen et
al.’s [1] call is timely and IV analysis, and other related
techniques (e.g. directed acyclic graphs, propensity score
matching and selection models), should be considered more
widely in behavioural medicine [14, 21–23].
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